secwatch.observer — SEC 8-K summary
======================================

Issuer:     Equillium, Inc. (EQ)
CIK:        0001746466
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001193125-25-177510
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Equillium raises $30M in private placement; cash runway through 2027
--------------------------------------------------------------------

- Initial closing of 21.8M shares at $0.57/sh and pre-funded warrants for 30.8M shares, gross proceeds $30M.
- Potential milestone closing of up to $20M upon IND clearance or first patient dosing for EQ504 and stock price threshold.
- Net proceeds expected to extend cash runway through 2027, prioritizing EQ504 development.
- Company has not initiated cryptocurrency treasury reserve strategy as previously announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746466/000119312525177510/0001193125-25-177510-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746466/000119312525177510/d448302d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-177510

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer